Category: health
Our mission is to provide health care tips empowering, evidence-based information that you can use to help yourself and your loved ones. Our health blogs help you help yourself by offering guidance and encouragement. By following our blogs you will start feeling better. We aim to provide articles that give the audience better information that can improve their lives. Our blogs cover topics such as health, fitness and their supplements. Also, it focuses on the essential things you need to know to understand the problem you’re facing, make informed decisions, and take positive steps. We deliver our readers a better online experience. Read on!
India to seek pharma IPR waiver for future pandemics
[ad_1] India is likely to push for a global patent waiver for vaccines, therapeutics, and diagnostics to combat future pandemics at the mini-ministerial meeting of the World Trade Organization (WTO) in Paris next month, after securing a five-year waiver for Covid-19 vaccines in 2022. India, South Africa, and 80 other WTO members had proposed a ...
narcl: NARCL offers to buy Rs 1,100 crore loans of Parenteral Drugs
[ad_1] Government-owned asset reconstruction company, the National Asset Reconstruction Co (NARCL), has offered to acquire around ₹1,100 crore in loans of Parenteral Drugs (India) from the State Bank of India (SBI) and Punjab National Bank (PNB). The offer has triggered a Swiss challenge auction, said two people aware of the development. NARCL has offered ₹45 ...
Sanofi India: Sanofi board approves demerger of its consumer healthcare business
[ad_1] Drug firm Sanofi India on Wednesday said its board has approved the demerger of its consumer healthcare business into a separate entity. The company’s board has approved the Scheme of Arrangement between Sanofi India Ltd (SIL) and its wholly-owned subsidiary Sanofi Consumer Healthcare India Ltd (SCHIL), the drug maker said in a statement. The ...
Drug pricing regulator looking to make vital health supplements more affordable
[ad_1] India‘s drug pricing regulator is considering capping prices of vital medicines like vitamin A, vitamin C, glycerine and anti-tetanus immunoglobulin to curb profiteering by the pharmaceutical companies. The National Pharmaceutical Pricing Authority (NPPA) proposes to invoke extraordinary powers in public interest, under para 19 of Drugs Prices Control Order (DPCO) 2013, for an indefinite ...
End of Covid emergency to affect sales of diagnostics cos: Report
[ad_1] With the World Health Organisation (WHO) declaring that Covid-19 is no longer a global emergency, medical device companies are likely to see a decrease in sales, according to a report on Tuesday. In the last three years of the pandemic, many medical device companies made billions through tests and pharmaceuticals. The report by data ...
QR Codes: Centre’s stand sought on PIL for QR codes on medicinal, food products
[ad_1] The Delhi High Court on Tuesday sought the Centre’s stand on a public interest litigation seeking affixation of QR codes on all medicinal and food products to make them accessible to the visually impaired. A bench of Chief Justice Satish Chandra Sharma and Justice Subramonium Prasad issued notice to the central government, Food Safety ...
syngene international: Syngene International sees strong momentum this fiscal year: MD
[ad_1] Syngene International expects strong business momentum in this financial year, said its MD Jonathan Hunt. In an interview to ET, he said biotech and pharma companies in the US and Europe are set to outsource more discovery, development and manufacturing work to companies like Syngene with relative cost advantage, as they battle high inflation, ...
india: India ready to lead technology-driven diabetes care: Jitendra Singh
[ad_1] Union minister Jitendra Singh on Sunday said India is fast becoming a huge medical tourism hub and it is ready to lead technology-driven diabetes care. Addressing the three-day World Congress of ‘Diabetes Technology and Therapeutics 2023’ (DTechCon 2023) in New Delhi, he said the country is being looked up to by the rest of ...
sun pharma: Sun Pharma recalls over 24K prefilled syringes of generic medication in the US
[ad_1] Drug major Sun Pharmaceutical Industries is recalling pre-filled syringes of a drug, used to treat infertility in women, in the US market due to a manufacturing issue, according to the US health regulator. In its latest Enforcement Report, the US Food and Drug Administration (USFDA) noted that the Mumbai-based drug major is recalling 24,194 ...
medisol: Lupin to acquire French firm Medisol for around Rs 160 cr
[ad_1] Pharmaceuticals firm Lupin Ltd on Friday said it will fully acquire French pharmaceutical company Medisol for 18 million euros (over Rs 160 crore). The company has entered into a definitive agreement to acquire the entire share capital of Medisol, subject to approval from the French Ministry of Economy and Finance, Lupin said in a ...